Advanced company searchLink opens in new window

PHARMACYX LTD

Company number 12645182

Filter by category

Filter by category


Confirmation statement filters

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
05 Sep 2024 AA Total exemption full accounts made up to 31 March 2024
11 Jul 2024 CS01 Confirmation statement made on 3 June 2024 with updates
25 Sep 2023 PSC01 Notification of Paul Robert Mayberry as a person with significant control on 1 April 2023
25 Sep 2023 SH01 Statement of capital following an allotment of shares on 1 April 2023
  • GBP 3
16 Aug 2023 AA Unaudited abridged accounts made up to 31 March 2023
13 Jul 2023 PSC04 Change of details for Benjamin Drew Mayberry as a person with significant control on 6 June 2021
21 Jun 2023 CS01 Confirmation statement made on 3 June 2023 with no updates
21 Nov 2022 AAMD Amended accounts made up to 31 March 2022
09 Aug 2022 AA Unaudited abridged accounts made up to 31 March 2022
09 Jun 2022 CS01 Confirmation statement made on 3 June 2022 with no updates
30 Dec 2021 AA Micro company accounts made up to 31 March 2021
08 Dec 2021 CERTNM Company name changed mbbm healthcare technologies LTD\certificate issued on 08/12/21
  • NM01 ‐ Change of name by resolution
  • RES15 ‐ Change company name resolution on 2021-12-07
25 Jun 2021 AA01 Previous accounting period shortened from 30 June 2021 to 31 March 2021
25 Jun 2021 CS01 Confirmation statement made on 3 June 2021 with updates
28 Apr 2021 AP01 Appointment of Mr Matthew Kenneth John Bridges as a director on 28 April 2021
28 Apr 2021 PSC01 Notification of Matthew Kenneth John Bridges as a person with significant control on 6 June 2020
04 Jun 2020 NEWINC Incorporation
  • MODEL ARTICLES ‐ Model articles adopted

Statement of capital on 2020-06-04
  • GBP 1